Archives

by in
Entry Author Date Location
More Biotechs Belly-Up These Days but Dendreon Still “One of a Kind” 12/02/14 National
West Coast Biotech Roundup: Gilead, Juno, Hutch, Fibrogen & More 11/20/14 Seattle
Juno, Less Than a Year Old, Lines up IPO to Fund Cancer Work 11/17/14 Seattle
East Coast Biotech Roundup: Sarepta, Aegerion, Syros, Aileron & More 10/31/14 Boston
Syros Raises $53M More To Push Gene-Control Drugs Into Human Trials 10/27/14 Boston
Six Takeaways from Boston’s Life Science Disruptors 10/13/14 Boston
Sold For Parts, Accelerator Grad Allozyne Reaches End of the Line 09/18/14 Seattle
Scholar Rock’s Local Approach to Immune Disease Nabs $20M 09/15/14 Boston
John Maraganore: From “Prototypical Geek” To Canny Alnylam Chief 09/07/14 Boston
West Coast Biotech Roundup: ARCH, Ebola, ViaCyte, Calithera & More 08/28/14 San Francisco
ARCH Venture Exploits IPO Window To Raise $400M Fund, Its Eighth 08/27/14 Seattle
Coelacanths And Other IPO Thoughts Before The Autumn Markets Return 08/26/14 National
To Take On New York, Accelerator Makes Big Changes 08/14/14 New York
West Coast Biotech Roundup: MappBio, Juno, Zosano, and More 08/07/14 San Diego
With $310M and Public Investors Aboard, Is a Juno IPO Next? 08/05/14 Seattle
East Coast Biotech Roundup: Emulate, Accelerator, Retrophin, & More 08/01/14 Boston
Seattle Jobs? Big Biotech Gives And Takes Away (Mostly The Latter) 07/29/14 Seattle
Accelerator Bags $51M, Makes Long-Awaited Move to NYC 07/29/14 New York
East Coast Biotech Roundup: Acceleron, Seres, Sage, & More 07/18/14 Boston
Sage, Despite Industry-Wide Pullback, Scores $90M in Upsized IPO 07/17/14 Boston
Who Needs Biotech VCs, Anyway? 07/15/14 San Francisco
BIO 2014: An Industry Surrounded by Insurmountable Opportunity 06/19/14 San Diego
Sage Therapeutics Readies IPO Pitch to Develop CNS Drugs 06/18/14 Boston
Amid Court Fight and Trial Pauses, Juno Closes First Round at $176M 04/24/14 Seattle
Just 7 Tickets Left for Our What’s Hot in Cancer Event April 22 04/21/14 Seattle
Agios’s Blood Cancer Drug Shines in First Clinical Test 04/06/14 Boston
East Coast Biotech Roundup: ImmusanT, NY Disruptors, Tesaro, & More 03/14/14 Boston
Sage Therapeutics Grabs $38M More For CNS Drugs 03/13/14 Boston
SAGE Therapeutics Lands $38,000,000 Series C Round 03/13/14 Boston
Join Xconomy for ‘What’s Hot in Cancer Immunotherapy’ on April 22 02/20/14 Seattle
Page 1 of 13 next page »